Istituto Gentili

Istituto Gentili is an Italian pharmaceutical company with the mission of providing innovative treatment solutions in the fields of oncology, hematology-oncology, and rare diseases. In recent years, Istituto Gentili has supported its growth through external expansion, benefiting from subsequent acquisitions and collaborations with multinational pharmaceutical companies. These efforts have strengthened its product portfolio, offering targeted therapies for serious malignancies such as breast cancer and non-Hodgkin lymphoma, as well as supportive treatments for cancer-related conditions like neutropenia, oropharyngeal mucositis, and breakthrough pain.